Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Empowering Practitioners: Harnessing Real-World Evidence for Better Outcomes in Portopulmonary Hypertension

Empowering Practitioners: Harnessing Real-World Evidence for Better Outcomes in Portopulmonary Hypertension

Introduction

In the dynamic field of speech-language pathology, practitioners are constantly seeking evidence-based approaches to enhance therapeutic outcomes. While our primary focus is on communication disorders, it's crucial to recognize the interconnectedness of various health domains. The recent study titled "Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies" offers valuable insights that can indirectly inform our practice, especially when considering the holistic health of our clients.

Understanding the Study

Portopulmonary hypertension (PoPH) is a severe form of pulmonary arterial hypertension (PAH) associated with portal hypertension, often complicating the clinical picture for affected individuals. The study in question provides real-world evidence on the safety and efficacy of macitentan, a PAH-specific therapy, in treating PoPH. The data was drawn from the OPUS and OrPHeUS studies, which collectively included 206 patients with PoPH.

Key Findings

Implications for Practitioners

As practitioners, it's essential to be aware of the broader health challenges our clients may face, including those related to systemic conditions like PoPH. While our primary role may not involve direct management of such conditions, understanding the therapeutic landscape can enhance our ability to collaborate with multidisciplinary teams and advocate for comprehensive care.

Here are some ways practitioners can leverage this knowledge:

Encouraging Further Research

The findings from the OPUS/OrPHeUS studies underscore the importance of real-world evidence in informing clinical practice. Practitioners are encouraged to stay informed about ongoing research in related health domains and consider how emerging data can be integrated into their practice.

To deepen your understanding of the study and its implications, you can access the full research paper: Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies.

Conclusion

By staying informed and integrating insights from diverse health domains, speech-language pathologists can enhance their practice and contribute to improved outcomes for children and individuals with complex health needs. Let's continue to embrace data-driven approaches and advocate for holistic care in our therapeutic endeavors.


Citation: Kim, N. H., Chin, K. M., McLaughlin, V. V., DuBrock, H., Restrepo-Jaramillo, R., Safdar, Z., MacDonald, G., Martin, N., Rosenberg, D., & Solonets, M. (2024). Safety of macitentan for the treatment of portopulmonary hypertension: Real-world evidence from the combined OPUS/OrPHeUS studies. Pulmonary Therapy. https://doi.org/10.1007/s41030-023-00251-x
Marnee Brick, President, TinyEYE Therapy Services

Author's Note: Marnee Brick, TinyEYE President, and her team collaborate to create our blogs. They share their insights and expertise in the field of Speech-Language Pathology, Online Therapy Services and Academic Research.

Connect with Marnee on LinkedIn to stay updated on the latest in Speech-Language Pathology and Online Therapy Services.

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP